"As a purely speculative view, one wonders what the broader implications of a treatment like this can be. If it can be used to improve cognitive function in those that have suffered brain injuries, what can the drug do for a ‘healthy’ brain. Could it be used as a (hopefully legal) performance enhancing drug where people like you and I could improve cognitive function, memory and general brain health? That would make this market pretty far reaching."
This is something I never considered... I don't have the technical expertise, but does anyone on here who does think this is a possibility?
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren Investor Presentation, 11 January 2016
NEU
neuren pharmaceuticals limited
Add to My Watchlist
11.2%
!
$13.95

Ann: Neuren Investor Presentation, 11 January 2016, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.95 |
Change
1.410(11.2%) |
Mkt cap ! $1.728B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $5.891M | 434.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 532 | $13.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.95 | 383 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 362 | 13.970 |
2 | 21 | 13.960 |
2 | 582 | 13.950 |
4 | 726 | 13.940 |
1 | 450 | 13.930 |
Price($) | Vol. | No. |
---|---|---|
13.980 | 513 | 4 |
13.990 | 4687 | 5 |
14.000 | 39678 | 12 |
14.010 | 1671 | 6 |
14.020 | 1547 | 6 |
Last trade - 11.06am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online